98 related articles for article (PubMed ID: 7618188)
21. On the mechanism of opioid-oestradiol interactions.
Vértes M; Pámer Z; Garai J
J Steroid Biochem; 1986 Jan; 24(1):235-8. PubMed ID: 3009977
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo inhibition of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
Ho SM; Viccione T; Yu M
J Steroid Biochem Mol Biol; 1993 Oct; 46(4):489-95. PubMed ID: 8217879
[TBL] [Abstract][Full Text] [Related]
23. Nuclear type II [3H]estradiol binding sites: a histone H3-H4 complex.
Shoulars K; Rodrigues MA; Crowley JR; Turk J; Thompson T; Markaverich BM
J Steroid Biochem Mol Biol; 2005 Jun; 96(1):19-30. PubMed ID: 15878266
[TBL] [Abstract][Full Text] [Related]
24. An endogenous ligand for type II binding sites in normal and neoplastic tissues.
Clark JH; Markaverich BM
Adv Exp Med Biol; 1986; 196():305-15. PubMed ID: 3716924
[TBL] [Abstract][Full Text] [Related]
25. In vitro effects of cytosolic inhibitor and opiates on the binding of [3H]oestradiol to nuclear type II binding sites of rat uterus and hypothalamus.
Garai J; Vértes M; Kovács S
J Steroid Biochem; 1989 Mar; 32(3):433-8. PubMed ID: 2704239
[TBL] [Abstract][Full Text] [Related]
26. Estrogen affinity crosslinking to tyrosinase-like immunoreactive proteins of rat uterine nuclear extracts.
Garai J; Clark JH
J Steroid Biochem Mol Biol; 1994 Jun; 49(2-3):161-5. PubMed ID: 8031712
[TBL] [Abstract][Full Text] [Related]
27. Assay of nuclear estradiol receptor by exchange on glass fiber filters.
Levy C; Eychenne B; Robel P
Biochim Biophys Acta; 1980 Jun; 630(2):301-5. PubMed ID: 6248131
[TBL] [Abstract][Full Text] [Related]
28. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
Markaverich BM; Roberts RR; Alejandro M; Clark JH
Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
[TBL] [Abstract][Full Text] [Related]
29. An exchange assay for estrogen receptors in cell nuclei of the adult rat brain.
Roy EJ; McEwen BS
Steroids; 1977 Nov; 30(5):657-69. PubMed ID: 611633
[TBL] [Abstract][Full Text] [Related]
30. Nuclear type II [3H]estradiol binding site ligands: inhibition of ER-positive and ER-negative cell proliferation and c-Myc and cyclin D1 gene expression.
Markaverich BM; Shoulars K; Alejandro MA
Steroids; 2006 Oct; 71(10):865-74. PubMed ID: 16839579
[TBL] [Abstract][Full Text] [Related]
31. Radioligand exchange binding cannot directly determine the dissociation constant (Kd) of the rat ventral prostate nuclear androgen receptor: valid Kd determinations require additional uptake binding data.
Chapman JC; Freeh SM; Michael SD
Arch Biochem Biophys; 1993 Dec; 307(2):242-7. PubMed ID: 8274009
[TBL] [Abstract][Full Text] [Related]
32. Binding of [3H]angiotensin II and [3H]DuP 753 (Losartan) to rat liver homogenates reveals multiple sites. Relationship to AT1a- and AT1b-type angiotensin receptors and novel nonangiotensin binding sites.
Widdowson PS; Renouard A; Vilaine JP
Peptides; 1993; 14(4):829-37. PubMed ID: 8234032
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of nuclear binding sites for oestradiol in rat testicular and uterine tissue. Determination of low amounts of specific binding site by an [3H] oestradiol-exchange method.
de Boer W; de Vries J; Mulder E; van der Molen HJ
Biochem J; 1977 Feb; 162(2):331-9. PubMed ID: 849288
[TBL] [Abstract][Full Text] [Related]
35. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
36. Type II estrogen binding site agonist: synthesis and biological evaluation of the enantiomers of methyl-para-hydroxyphenyllactate (MeHPLA).
Pretlow L; Williams R; Elliott M
Chirality; 2003 Oct; 15(8):674-9. PubMed ID: 12923805
[TBL] [Abstract][Full Text] [Related]
37. Ultraviolet photosensitivity of the estrogen binding protein from rat uterus. Wavelength and ligand dependence. Photocovalent attachment of estrogens to proteins.
Katzenellenbogen JA; Ruh TS; Carlson KE; Iwamoto HS; Gorski J
Biochemistry; 1975 Jun; 14(11):2310-6. PubMed ID: 166653
[TBL] [Abstract][Full Text] [Related]
38. Identification of uterine nuclear type II estrogen binding sites in estrogen treated rats.
Sheehan DM; Medlock KL; Lyttle CR
J Steroid Biochem; 1986 Jul; 25(1):37-43. PubMed ID: 3747514
[TBL] [Abstract][Full Text] [Related]
39. Nuclear type-ii [h-3] estradiol binding-sites in mcf-7 human breast-cancer cells - binding interactions with 2,6-bis-([3,4-dihydroxyphenyl]-methylene)cyclohexanone esters and inhibition of cell-proliferation.
Markaverich B; Varma M; Densmore C; Tiller A; Schauweker T; Gregory R
Int J Oncol; 1994 Jun; 4(6):1291-300. PubMed ID: 21567051
[TBL] [Abstract][Full Text] [Related]
40. Relationship between type I and type II estrogen binding sites in the rat uterus.
Moses DF; Fridman O; De Nicola AF
Acta Physiol Pharmacol Latinoam; 1985; 35(4):451-7. PubMed ID: 2940805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
